Poster

Safety and Efficacy of Low-Sodium Oxybate in Participants With Narcolepsy With and Without Psychiatric Comorbidities: Subgroup Analysis of a Phase 3 Clinical Trial

This study assessed safety and efficacy of low-sodium oxybate (LXB) in participants with narcolepsy both with and without comorbid psychiatric disorders in a phase 3 clinical study. Safet...

Craig Chepke , MD, DFAPA;

10/26/2023

Safety and Tolerability of Zuranolone 50 mg in Patients with Major Depressive Disorder: Results from the Phase 3 WATERFALL and CORAL Studies

Zuranolone 50 mg initiated alone (WATERFALL Study) or co-initiated with a standard-of-care antidepressant (CORAL Study) was well-tolerated in adults with major depressive disorder. In WAT...

Cole Brown , MD;

10/26/2023

Screening for Obsessive Compulsive Disorder among college students using the Obsessive Compulsive Inventory-4

This study aimed to assess the efficacy of the Obsessive Compulsive Inventory questionnaire (OCI-4), a four-item OCD screening tool used to detect OCD, in a cohort of college students. Th...

10/26/2023

Shaping Psychiatric Pharmacy Through Stewardship and Standardized Outcomes

The American Association of Psychiatric Pharmacists (AAPP) has sought to operationalize the concept of psychotropic stewardship through formalizing a consensus-based set of outcomes and m...

Jonathan Lister , PharmD, BCPP;

10/26/2023

Real-World Antipsychotic Treatment Modification With and Without Deutetrabenazine in Patients Newly Diagnosed With Tardive Dyskinesia

Tardive dyskinesia (TD) management includes antipsychotic (AP) dose modification/discontinuation, often leaving underlying psychiatric conditions undertreated. Deutetrabenazine (DTBZ) is ...

Marko Mychaskiw , PhD;

10/26/2023

Real-World Effectiveness of Deutetrabenazine When Initiated Using a 4-Week Patient Titration Kit: Interim Results of the START Study

START is an ongoing, noninterventional, prospective, single-arm, 2-cohort (tardive dyskinesia [TD] and Huntington disease) study evaluating the effectiveness of deutetrabenazine initiated...

Andrew J. Cutler , MD;

10/26/2023

Real-World Observational Study of Implementation and Evaluation of the Pathway Platform: A Digitally Enabled Care Pathway to Improve Depression Management in Primary Care

The Pathway Platform supports MBC for patients with MDD by integrating a patient-facing app with EHR. This real-world Pathway Platform implementation study in primary care demonstrated si...

Christopher Blair , MS;

10/26/2023

Real-World Safety Profile of Esketamine Nasal Spray During the First 12 Treatment Sessions: An Analysis at 46 Months After Approval in the United States

This research examined real-world safety data for esketamine nasal spray (ESK) for the first 46 months after product approval, with a focus on adverse events (AEs) of interest (i.e., seda...

Hannah Bowrey , PhD;

10/26/2023

Relapse Rates With Paliperidone Palmitate in Adult Patients With Schizophrenia: Results for the 6-Month Formulation From an Open-label Extension Study Compared to Real-world Data for the 1-Month and 3-Month Formulations

Compare efficacy of the three paliperidone palmitate (PP) long-acting injectable formulations for relapse prevention in schizophrenia: Relapse in schizophrenia has pronounced consequences...

Ibrahim Turkoz , PhD;

10/26/2023

Reliable, Scalable Assessment in Routine Practice-Implementing Rapid Clozapine Blood Levels in the Real World

The project's objective was to implement rapid clozapine blood level testing at a large academic medical center. Upon implementation, the time to receive test results improved from 87.4 h...

Megan J. Ehret , PharmD, MS, BCPP;

10/26/2023